✦ LIBER ✦

Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer

✍ Scribed by Płuż;zańska, A.; Jassem, J.; Jelič, S.; Gorbunova, V.; Mrsič-Krmpotič, Z.; Berzins, J.; Nagykálnai, T.; Wigler, N.; Renard, J.; Statuch, C.

Book ID: 122899925
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 152 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81676-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and Doxorubicin Compared With

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

✍ Nabholtz, J.-M. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 150 KB

A phase III trial of taxotere and doxoru

A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysis

✍ K. Bouzid; J. Vinholes; F. Salas; E. Mickiewicz; S. Valdivia; V. Ostapenko; E. B 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Multicenter Randomized Trial Comparing S

Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study

✍ Alba, E. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 307 KB

669 A phase III randomized trial of bend

669 A phase III randomized trial of bendamustinehydrochloride, methotrexate, and 5-FU (BMF) versus CMF as first-line treatment of patients with metastatic breast cancer

✍ G. von Minckwitz; I. Chemozemsky; R. Souchon; N. Stuart; J. Vermorken; K. Merkle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Multicenter Phase III Randomized Trial C

Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens

✍ Valero, V.; Forbes, J.; Pegram, M. D.; Pienkowski, T.; Eiermann, W.; von Minckwi 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB

FOXFIRE protocol: an open-label, randomi

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer

✍ Susan J Dutton,Nicola Kenealy,Sharon B Love,Harpreet S Wasan… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 333 KB